| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.11.23 | Braincool AB: BrainCool AB (publ) - interim report for Q3 2023 | 25 | GlobeNewswire (Europe) | BrainCool GroupPeriod in briefJul-Sep2023Jan-Sep 2023Full Year 2022Net Sales3 63813 67217 588EBITDA-9 263-34 522-31 924EBIT-10 449-38 084-36 679Result after tax-10 882-39 234-45 613Cashflow from operating... ► Artikel lesen | |
| 03.11.23 | HusCompagniet A/S: Trading Statement for 1 January - 30 September 2023 | 126 | GlobeNewswire (Europe) | Company Announcement 27/2023
Outlook for 2023 Reconfirmed
HusCompagniet generated a revenue of DKK 571 million and EBITDA of DKK 33 million bringing the year-to-date revenue to DKK 1,851 million... ► Artikel lesen | |
| 03.11.23 | Cell Impact Q3 2023: Low demand but continued high interest | 378 | GlobeNewswire (Europe) | Cell Impact AB (Nasdaq First North GM: CI) reports the following summary for the third quarter 2023.
The third quarter was a weak period in line with the expectations that Cell Impact communicated... ► Artikel lesen | |
| 03.11.23 | Shurgard Self Storage Ltd.: Third quarter 2023 results January 1, 2023 to September 30, 2023 | 272 | GlobeNewswire (Europe) | Continuing strong operational performance based on:
All stores revenue growth of 9.4% (at CER)(¹)
- In-place rent growth (+6.8%) and stable high occupancy (90.5%) for our same store pool
- Lower... ► Artikel lesen | |
| 03.11.23 | Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million | 281 | GlobeNewswire (Europe) | Korro will be focused on advancing a wholly owned portfolio of RNA editing programsPost-transaction cash of approximately $170 million expected to fund operations into 2026Funds multiple potentially... ► Artikel lesen | |
| 03.11.23 | Clarus Corporation: Clarus Announces $0.025 Per Share Quarterly Dividend | 301 | GlobeNewswire (Europe) | SALT LAKE CITY, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) ("Clarus" and/or the "Company"), a global company focused on the outdoor and consumer enthusiast markets, announced... ► Artikel lesen | |
| 03.11.23 | AutoZone, Inc.: AutoZone Announces Change to Executive Committee | 343 | GlobeNewswire (Europe) | MEMPHIS, Tenn., Nov. 03, 2023 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE: AZO) today announced that Lindsay Lehman, a three-year AutoZoner and Vice President, Marketing, has been promoted to Senior... ► Artikel lesen | |
| 03.11.23 | Mobiv Acquisition Corp. Provides Further Update on Planned Business Combination | 336 | GlobeNewswire (Europe) | Newark, DE, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Mobiv Acquisition Corp (the "Company" or "Mobiv") announced that it intends to enter into a Lock-Up Waiver, to be effective November 7, 2023, with the... ► Artikel lesen | |
| 03.11.23 | Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to December 3, 2023 | 183 | GlobeNewswire (Europe) | MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the "Company") a special purpose acquisition company, announced that on November 2, 2023, its... ► Artikel lesen | |
| 03.11.23 | Elicio Therapeutics Inc.: Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting | 293 | GlobeNewswire (Europe) | In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vaccine, as monotherapy, 87% (20/23) had direct ex... ► Artikel lesen | |
| 03.11.23 | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 222 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
| 03.11.23 | Scinai Immunotherapeutics Ltd.: Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance | 290 | GlobeNewswire (Europe) | JERUSALEM, Nov. 03, 2023 (GLOBE NEWSWIRE) -- via IBN - Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative... ► Artikel lesen | |
| 03.11.23 | Collective Audience, Inc.: Collective Audience Begins Trading Under New Nasdaq Ticker Symbol, CAUD | 479 | GlobeNewswire (Europe) | NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Collective Audience, Inc. (Nasdaq:CAUD), a leading provider of digital consumer acquisition solutions, announced its common stock has commenced trading... ► Artikel lesen | |
| 03.11.23 | Inozyme Pharma Inc.: Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 351 | GlobeNewswire (Europe) | BOSTON, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY)("Company" or "Inozyme"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the... ► Artikel lesen | |
| 03.11.23 | Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination | 202 | GlobeNewswire (Europe) | ATLANTA, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (Nasdaq: ALTUU, ALTU, ALTUW) ("Altitude"), announced today that its board of directors (the "Board"), upon request by Altitude's... ► Artikel lesen | |
| 03.11.23 | Aridis Pharmaceuticals, Inc.: Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update | 463 | GlobeNewswire (Europe) | Received two grant awards from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health LOS GATOS, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Aridis... ► Artikel lesen | |
| 03.11.23 | Aurora Technology Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Deadline to Consummate Business Combination | 150 | GlobeNewswire (Europe) | SAN FRANCISCO, CALIF., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Aurora Technology Acquisition Corp. (NASDAQ: ATAKU, ATAK, ATAKW, ATAKR) (the "Company") announced today that its sponsor, ATAC Sponsor LLC... ► Artikel lesen | |
| 03.11.23 | Earlyworks Co., Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency | 565 | GlobeNewswire (Europe) | Tokyo, Japan, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the "Company" or "Earlyworks"), a Japanese company operating its proprietary private blockchain technology, Grid... ► Artikel lesen | |
| 03.11.23 | Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting | 300 | GlobeNewswire (Europe) | - Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encouraging cytokine release profile across multiple dose... ► Artikel lesen | |
| 03.11.23 | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | 442 | GlobeNewswire (Europe) | FRAMINGHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 424 |
| BAYER | 272 |
| BYD | 240 |
| NVIDIA | 228 |
| NEL | 226 |
| PLUG POWER | 200 |
| TESLA | 191 |
| TUI | 189 |
| SUPER MICRO COMPUTER | 186 |
| DEUTSCHE BANK | 184 |
| APPLE | 182 |
| RHEINMETALL | 159 |
| RWE | 148 |
| AMAZON | 145 |
| DEUTSCHE LUFTHANSA | 144 |
| MERCEDES-BENZ | 142 |
| BERKSHIRE HATHAWAY | 127 |
| COMMERZBANK | 117 |
| BIONTECH | 116 |
| PAYPAL | 115 |
| ALLIANZ | 113 |
| AIXTRON SE | 111 |
| RENK GROUP | 111 |
| BASF | 110 |
| VOLKSWAGEN | 107 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
